Neonatal Screening Adds Three New Conditions

Newborns across France will now be screened for three additional diseases,expanding the country’s early detection program.These conditions – spinal muscular atrophy (SMA), congenital hypothyroidism, and X-linked adrenal insufficiency – will be added to the existing panel of tests performed shortly after birth.

Spinal Muscular Atrophy (SMA) is a rare genetic disease that affects motor neurons,leading to muscle weakness and atrophy. Early diagnosis and treatment,now possible through newborn screening,can significantly improve outcomes for babies with SMA. Learn more about SMA here.

Congenital Hypothyroidism occurs when a baby is born with an underactive thyroid gland. This can lead to developmental problems if not treated promptly. Screening allows for early hormone replacement therapy,ensuring normal growth and brain development. Find more information on congenital hypothyroidism.

X-linked Adrenal Insufficiency is a genetic disorder that affects the adrenal glands, which produce essential hormones. Early detection is crucial to prevent life-threatening adrenal crises. Read more about X-linked adrenal insufficiency.

Health officials believe that adding these three diseases to the screening program will help improve the health and well-being of newborns in France. The expanded screening is expected to identify more cases early, allowing for timely intervention and better long-term outcomes.